These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 22229217)
1. Phase III aflibercept-chemotherapy combination trial shows benefit in previously treated metastatic colorectal cancer patients. Oncology (Williston Park); 2011 Nov; 25(12):1213. PubMed ID: 22229217 [No Abstract] [Full Text] [Related]
2. Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. Van Cutsem E; Tabernero J; Lakomy R; Prenen H; Prausová J; Macarulla T; Ruff P; van Hazel GA; Moiseyenko V; Ferry D; McKendrick J; Polikoff J; Tellier A; Castan R; Allegra C J Clin Oncol; 2012 Oct; 30(28):3499-506. PubMed ID: 22949147 [TBL] [Abstract][Full Text] [Related]
3. Evolution of systemic therapy for metastatic colorectal cancer. Geh JI; Ma YT Colorectal Dis; 2011 Aug; 13(8):852-4. PubMed ID: 21762349 [No Abstract] [Full Text] [Related]
4. Safety and efficacy of radiofrequency ablation with aflibercept and FOLFIRI in a patient with metastatic colorectal cancer. Agarwal A; Daly KP; Butler-Bowen H; Saif MW Anticancer Res; 2014 Nov; 34(11):6775-8. PubMed ID: 25368290 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting. Lambrechts D; Thienpont B; Thuillier V; Sagaert X; Moisse M; Peuteman G; Pericay C; Folprecht G; Zalcberg J; Zilocchi C; Margherini E; Chiron M; Van Cutsem E Br J Cancer; 2015 Sep; 113(7):1027-34. PubMed ID: 26355232 [TBL] [Abstract][Full Text] [Related]
6. [Aflibercept (Zaltrap(®)) approved in metastatic colorectal cancer]. André T; Chibaudel B Bull Cancer; 2013 Oct; 100(10):1023-5. PubMed ID: 24047539 [TBL] [Abstract][Full Text] [Related]
7. Randomized, placebo-controlled, phase III study of oxaliplatin, fluorouracil, and leucovorin with or without PTK787/ZK 222584 in patients with previously treated metastatic colorectal adenocarcinoma. Van Cutsem E; Bajetta E; Valle J; Köhne CH; Hecht JR; Moore M; Germond C; Berg W; Chen BL; Jalava T; Lebwohl D; Meinhardt G; Laurent D; Lin E J Clin Oncol; 2011 May; 29(15):2004-10. PubMed ID: 21464401 [TBL] [Abstract][Full Text] [Related]
8. Bevacizumab in combination with chemotherapy: first-line treatment of patients with metastatic colorectal cancer. Hochster HS Semin Oncol; 2006 Oct; 33(5 Suppl 10):S8-14. PubMed ID: 17145525 [TBL] [Abstract][Full Text] [Related]
9. Metastatic colorectal cancer: is surgery necessary? Schmidt C J Natl Cancer Inst; 2009 Aug; 101(16):1113-5. PubMed ID: 19671774 [No Abstract] [Full Text] [Related]
10. Randomized, placebo-controlled, phase III study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor receptor inhibitor, in patients with metastatic colorectal adenocarcinoma. Hecht JR; Trarbach T; Hainsworth JD; Major P; Jäger E; Wolff RA; Lloyd-Salvant K; Bodoky G; Pendergrass K; Berg W; Chen BL; Jalava T; Meinhardt G; Laurent D; Lebwohl D; Kerr D J Clin Oncol; 2011 May; 29(15):1997-2003. PubMed ID: 21464406 [TBL] [Abstract][Full Text] [Related]
11. [Progress of chemotherapy in colorectal cancer]. Komatsu Y Gan To Kagaku Ryoho; 2007 Nov; 34(11):1771-6. PubMed ID: 18064761 [No Abstract] [Full Text] [Related]
12. Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better. Allegra C; George T; Yothers G J Natl Cancer Inst; 2011 Jan; 103(1):4-5. PubMed ID: 21123834 [No Abstract] [Full Text] [Related]
13. Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer. Tabernero J; Van Cutsem E; Díaz-Rubio E; Cervantes A; Humblet Y; André T; Van Laethem JL; Soulié P; Casado E; Verslype C; Valera JS; Tortora G; Ciardiello F; Kisker O; de Gramont A J Clin Oncol; 2007 Nov; 25(33):5225-32. PubMed ID: 18024868 [TBL] [Abstract][Full Text] [Related]
14. Gene expression of vascular endothelial growth factor A, thymidylate synthase, and tissue inhibitor of metalloproteinase 3 in prediction of response to bevacizumab treatment in colorectal cancer patients. Watanabe T; Kobunai T; Yamamoto Y; Matsuda K; Ishihara S; Nozawa K; Iinuma H; Ikeuchi H Dis Colon Rectum; 2011 Aug; 54(8):1026-35. PubMed ID: 21730794 [TBL] [Abstract][Full Text] [Related]
15. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study. Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495 [TBL] [Abstract][Full Text] [Related]
16. Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963). Innominato PF; Giacchetti S; Moreau T; Smaaland R; Focan C; Bjarnason GA; Garufi C; Iacobelli S; Tampellini M; Tumolo S; Carvalho C; Karaboué A; Lévi F; Chronobiol Int; 2011 Aug; 28(7):586-600. PubMed ID: 21859417 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-free intervals in patients with metastatic colorectal cancer: a tale of two cities? Beretta GD; Scartozzi M; Tondulli L; Cascinu S J Clin Oncol; 2010 Jun; 28(16):e268-9; author reply e270. PubMed ID: 20385975 [No Abstract] [Full Text] [Related]
18. Systemic chemotherapy for metastatic colorectal cancer: reasons to combine. Calvo E Clin Colorectal Cancer; 2002 Nov; 2(3):170-2. PubMed ID: 12482333 [No Abstract] [Full Text] [Related]
19. Fluorouracil, leucovorin and irinotecan associated with aflibercept can induce microscopic colitis in metastatic colorectal cancer patients. Ghiringhelli F; Vincent J; Beltjens F; Bengrine L; Ladoire S Invest New Drugs; 2015 Dec; 33(6):1263-6. PubMed ID: 26490656 [TBL] [Abstract][Full Text] [Related]
20. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer. Malik Z; Eng C Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584 [No Abstract] [Full Text] [Related] [Next] [New Search]